Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants.

Ledbetter J, Brannman L, Wade SW, Gonzales T, Kong AM.

J Med Econ. 2019 Aug 21:1. doi: 10.1080/13696998.2019.1658592. [Epub ahead of print]

PMID:
31432723
2.

TLR7/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA.

Lood C, Arve S, Ledbetter J, Elkon KB.

J Exp Med. 2017 Jul 3;214(7):2103-2119. doi: 10.1084/jem.20161512. Epub 2017 Jun 12.

3.

Pillars Article: A 39-kDa Protein on Activated Helper T Cells Binds CD40 and Transduces the Signal for Cognate Activation of B Cells. Proc. Natl. Acad. Sci. 1992. 89: 6550-6554.

Noelle RJ, Roy M, Shepherd DM, Stamenkovico I, Ledbetter JA, Aruffo A.

J Immunol. 2016 Dec 1;197(11):4195-4199. No abstract available.

4.

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.

Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ.

Nat Med. 2016 Feb;22(2):146-53. doi: 10.1038/nm.4027. Epub 2016 Jan 18.

5.

T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice.

Montes VN, Turner MS, Subramanian S, Ding Y, Hayden-Ledbetter M, Slater S, Goodspeed L, Wang S, Omer M, Den Hartigh LJ, Averill MM, O'Brien KD, Ledbetter J, Chait A.

PLoS One. 2013 Jul 2;8(7):e67709. doi: 10.1371/journal.pone.0067709. Print 2013.

6.

Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.

Sun X, Wiedeman A, Agrawal N, Teal TH, Tanaka L, Hudkins KL, Alpers CE, Bolland S, Buechler MB, Hamerman JA, Ledbetter JA, Liggitt D, Elkon KB.

J Immunol. 2013 Mar 15;190(6):2536-43. doi: 10.4049/jimmunol.1202689. Epub 2013 Feb 4.

7.

Plastic consumption and diet of Glaucous-winged Gulls (Larus glaucescens).

Lindborg VA, Ledbetter JF, Walat JM, Moffett C.

Mar Pollut Bull. 2012 Nov;64(11):2351-6. doi: 10.1016/j.marpolbul.2012.08.020. Epub 2012 Sep 17.

PMID:
22995785
8.

A two-question method for assessing gender categories in the social and medical sciences.

Tate CC, Ledbetter JN, Youssef CP.

J Sex Res. 2013;50(8):767-76. doi: 10.1080/00224499.2012.690110. Epub 2012 Sep 18.

PMID:
22989000
10.

Examining the impact of age and multitasking on motorcycle conspicuity.

Ledbetter JL, Boyce MW, Fekety DK, Sawyer B, Smither JA.

Work. 2012;41 Suppl 1:5384-5. doi: 10.3233/WOR-2012-0826-5384.

PMID:
22317558
11.

Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway.

Chaplin JW, Kasahara S, Clark EA, Ledbetter JA.

J Immunol. 2011 Oct 15;187(8):4199-209. doi: 10.4049/jimmunol.1100198. Epub 2011 Sep 14.

12.

Oversimplifying evolutionary psychology leads to explanatory gaps.

Tate C, Ledbetter JN.

Am Psychol. 2010 Dec;65(9):929-30. doi: 10.1037/a0021024.

PMID:
21133525
13.

Rapid activation of glutamate cysteine ligase following oxidative stress.

Krejsa CM, Franklin CC, White CC, Ledbetter JA, Schieven GL, Kavanagh TJ.

J Biol Chem. 2010 May 21;285(21):16116-24. doi: 10.1074/jbc.M110.116210. Epub 2010 Mar 23.

14.

CD20-directed small modular immunopharmaceutical, TRU-015, depletes normal and malignant B cells.

Hayden-Ledbetter MS, Cerveny CG, Espling E, Brady WA, Grosmaire LS, Tan P, Bader R, Slater S, Nilsson CA, Barone DS, Simon A, Bradley C, Thompson PA, Wahl AF, Ledbetter JA.

Clin Cancer Res. 2009 Apr 15;15(8):2739-46. doi: 10.1158/1078-0432.CCR-08-1694. Epub 2009 Apr 7.

15.
16.

Fighting foot-and-mouth disease in Mexico: popular protest against diplomatic decisions.

Ledbetter J.

Southwest Hist Q. 2001;104(3):386-415. No abstract available.

PMID:
18095399
17.

Complication of mediastinal mass: acquired tracheoesophageal fistula associated with T-cell lymphoblastic lymphoma.

Moree JS, Bhakta MG, Ledbetter J.

Pediatr Pulmonol. 2006 Jul;41(7):688-9. Review.

PMID:
16703600
18.

How does B cell depletion therapy work, and how can it be improved?

Clark EA, Ledbetter JA.

Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv77-80. Review.

19.

Significance of bifid epiglottis.

Stevens CA, Ledbetter JC.

Am J Med Genet A. 2005 May 1;134(4):447-9. Review.

PMID:
15782417
20.

Congenital bronchobiliary fistula: MRI appearance.

Hourigan JS, Carr MG, Burton EM, Ledbetter JC.

Pediatr Radiol. 2004 Apr;34(4):348-50. Epub 2003 Nov 7.

PMID:
14605784
21.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE.

Cancer Res. 2003 Jul 1;63(13):3695-700.

22.

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry.

Parnes C, Guillermin J, Habersang R, Nicholes P, Chawla V, Kelly T, Fishbein J, McRae P, Goessler M, Gatti A, Calcagno JA, Eki C, Harris KA, Joyave J, McFarland K, Protter P, Sullivan M, Stanford A, Lovett N, Ortiz M, Rojas S, Cyrus S, Cyrus J, Cohen S, Buchin D, Riordan L, Zuniga M, Shah R, Minard C, Quintin A, Douglas G, van Houten J, Freutner S, Chartrand S, Nowatzke P, Romero J, Rhodes T, Benoit M, Walter E, Walker L, DeBonnett L, Cross M, Free T, Martin S, Shank K, Guedes B, Atkinson LA, Halpin GJ, Rouse K, Hand I, Geiss D, Marshall JR, Burleson L, Boland J, Seybold K, Hunter V, Unfer S, Schmucker J, Gley M, Marcus M, Thompson P, Milla P, Young C, Zanni R, Zinno V, Fetter-Zarzeka A, Busey A, Sokunbi MA, Airington S, Richard N, Muraligopal V, Lewis S, Weber FT, Giordano BP, Linehan D, Roach J, Davis R, Rzepka AA, Booth T, Smeltzer D, Walsh J, Arispe E, Rowley R, Bolling C, Botts T, Haskett K, Raby D, Batiz E, Gelfand A, Farrell L, Butler S, Colby L, Schochet P, Bentler J, Hirsch D, Wilkinson L, Aaronson A, Bennett E, Wingate J, Quinn D, Komendowski K, Deckard M, Frogel M, Nerwen C, Copenhaver S, Prater M, Wolsztein J, Mackey K, Benbow M, Naranjo M, Hensley S, Hayes C, Sadeghi H, Lawson SM, McCall M, Combs K, Ledbetter J, Sarnosky K, Swafford C, Speer M, Barton WJ, Mink JW, Lemm D, Hudak M, Case E, Rowen J, Fuentes S, Pane C, Richardson L, Chavarria C, Cassino D, Ghaffari K, Carroll C, Lee H, Guclu L, Johnson C, Blum V, Boron ML, Sorrentino M, Hirsch RL, Van Veldhuisen PC, Smith C; Palivizumab Outcomes Registry Study Group.

Pediatr Pulmonol. 2003 Jun;35(6):484-9.

PMID:
12746948
23.

Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complex.

Law CL, Hayden-Ledbetter M, Buckwalter S, McNeill L, Nguyen H, Habecker P, Thorne BA, Dua R, Ledbetter JA.

Int Immunol. 2002 Apr;14(4):389-400.

PMID:
11934875
24.

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.

Ye Z, Hellström I, Hayden-Ledbetter M, Dahlin A, Ledbetter JA, Hellström KE.

Nat Med. 2002 Apr;8(4):343-8.

PMID:
11927939
25.

Cutting edge: CD83 regulates the development of cellular immunity.

Scholler N, Hayden-Ledbetter M, Dahlin A, Hellström I, Hellström KE, Ledbetter JA.

J Immunol. 2002 Mar 15;168(6):2599-602.

26.

Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells.

Richter G, Hayden-Ledbetter M, Irgang M, Ledbetter JA, Westermann J, Körner I, Daemen K, Clark EA, Aicher A, Pezzutto A.

J Biol Chem. 2001 Dec 7;276(49):45686-93. Epub 2001 Sep 24.

27.

ICOS ligand costimulation is required for T-cell encephalitogenicity.

Sporici RA, Beswick RL, von Allmen C, Rumbley CA, Hayden-Ledbetter M, Ledbetter JA, Perrin PJ.

Clin Immunol. 2001 Sep;100(3):277-88.

PMID:
11513541
28.

Monoclonal antibodies raised to human cells--specificity for pig leukocytes.

Haverson K, Bailey M, Stokes CR, Simon A, LeFlufy L, Banfield G, Chen Z, Hollemweguer E, Ledbetter JA.

Vet Immunol Immunopathol. 2001 Jul 20;80(1-2):175-86.

PMID:
11445227
29.

Summary of the first round analyses of the Third International Workshop on Swine Leukocyte Differentiation Antigens.

Haverson K, Saalmüller A, Chen Z, Huang CA, Simon A, Seebach J, Boersma WJ, Zwart R, Niewold TA, Thacker E, Llanes D, de la Lastra JM, Engelhardt H, Ezquerra A, Alonso F, Dominguez J, Ledbetter JA, Grosmaire L, Lee R, Nielsen J, Salmon H, Valpotic I, Sver L, Lackovic G, Summerfield A, Khanna KV.

Vet Immunol Immunopathol. 2001 Jul 20;80(1-2):25-34.

PMID:
11445216
30.

Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens.

Haverson K, Saalmüller A, Alvarez B, Alonso F, Bailey M, Bianchi AT, Boersma WJ, Chen Z, Davis WC, Dominguez J, Engelhardt H, Ezquerra A, Grosmaire LS, Hamilton MJ, Hollemweguer E, Huang CA, Khanna KV, Kuebart G, Lackovic G, Ledbetter JA, Lee R, Llanes D, Lunney JK, McCullough KC, Molitor T, Nielsen J, Niewold TA, Pescovitz MD, de la Lastra JM, Rehakova Z, Salmon H, Schnitzlein WM, Seebach J, Simon A, Sinkora J, Sinkora M, Stokes CR, Summerfield A, Sver L, Thacker E, Valpotic I, Yang H, Zuckermann FA, Zwart R.

Vet Immunol Immunopathol. 2001 Jul 20;80(1-2):5-23.

PMID:
11445215
31.

CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer.

Hellstrom I, Ledbetter JA, Scholler N, Yang Y, Ye Z, Goodman G, Pullman J, Hayden-Ledbetter M, Hellstrom KE.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6783-8. Epub 2001 May 22.

32.

CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected].

Scholler N, Hayden-Ledbetter M, Hellström KE, Hellström I, Ledbetter JA.

J Immunol. 2001 Mar 15;166(6):3865-72. Erratum in: J Immunol. 2009 Feb 1;182(3):1772-3.

33.

Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells.

Shan D, Ledbetter JA, Press OW.

Cancer Immunol Immunother. 2000 Mar;48(12):673-83.

PMID:
10752475
34.

A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease.

Fujihara SM, Cleaveland JS, Grosmaire LS, Berry KK, Kennedy KA, Blake JJ, Loy J, Rankin BM, Ledbetter JA, Nadler SG.

J Immunol. 2000 Jul 15;165(2):1004-12.

35.

Characterization of human inducible costimulator ligand expression and function.

Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, Buckwalter S, Ledbetter JA, Clark EA.

J Immunol. 2000 May 1;164(9):4689-96.

36.

IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells.

Skov S, Bonyhadi M, Odum N, Ledbetter JA.

J Immunol. 2000 Apr 1;164(7):3500-5.

37.

On the costs of accessible attitudes: detecting that the attitude object has changed.

Fazio RH, Ledbetter JE, Towles-Schwen T.

J Pers Soc Psychol. 2000 Feb;78(2):197-210.

PMID:
10707329
38.

Construction, expression, and characterization of anticarcinoma sFv fused to IL-2 or GM-CSF.

Zhao L, Rai SK, Grosmaire LS, Ledbetter JA, Fell HP.

J Hematother Stem Cell Res. 1999 Aug;8(4):393-9.

PMID:
10634177
39.

Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths.

Shan D, Press OW, Tsu TT, Hayden MS, Ledbetter JA.

J Immunol. 1999 Jun 1;162(11):6589-95.

40.

Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes.

Connelly RJ, Hayden MS, Scholler JK, Tsu TT, Dupont B, Ledbetter JA, Kanner SB.

Int Immunol. 1998 Dec;10(12):1863-72.

PMID:
9885907
41.

A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.

Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, Troutt AB, Ledbetter JA, Deeg HJ.

Br J Haematol. 1998 Oct;103(1):176-88.

PMID:
9792306
42.

A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.

Bikah G, Lynd FM, Aruffo AA, Ledbetter JA, Bondada S.

Int Immunol. 1998 Aug;10(8):1185-96.

PMID:
9723705
43.

Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies.

Shan D, Ledbetter JA, Press OW.

Blood. 1998 Mar 1;91(5):1644-52.

PMID:
9473230
44.

HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand.

Lee JW, Gersuk GM, Kiener PA, Beckham C, Ledbetter JA, Deeg HJ.

J Immunol. 1997 Oct 1;159(7):3211-9.

PMID:
9317119
45.

Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation.

Kiener PA, Davis PM, Rankin BM, Klebanoff SJ, Ledbetter JA, Starling GC, Liles WC.

J Immunol. 1997 Aug 15;159(4):1594-8.

PMID:
9257817
46.

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.

Shuford WW, Klussman K, Tritchler DD, Loo DT, Chalupny J, Siadak AW, Brown TJ, Emswiler J, Raecho H, Larsen CP, Pearson TC, Ledbetter JA, Aruffo A, Mittler RS.

J Exp Med. 1997 Jul 7;186(1):47-55.

47.

In vivo efficacy and toxicity of a single-chain immunotoxin targeted to CD40.

Francisco JA, Schreiber GJ, Comereski CR, Mezza LE, Warner GL, Davidson TJ, Ledbetter JA, Siegall CB.

Blood. 1997 Jun 15;89(12):4493-500.

PMID:
9192773
48.

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors.

Melero I, Shuford WW, Newby SA, Aruffo A, Ledbetter JA, Hellström KE, Mittler RS, Chen L.

Nat Med. 1997 Jun;3(6):682-5.

PMID:
9176498
49.

Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-kappaB.

Krejsa CM, Nadler SG, Esselstyn JM, Kavanagh TJ, Ledbetter JA, Schieven GL.

J Biol Chem. 1997 Apr 25;272(17):11541-9.

50.

Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages.

Kiener PA, Davis PM, Starling GC, Mehlin C, Klebanoff SJ, Ledbetter JA, Liles WC.

J Exp Med. 1997 Apr 21;185(8):1511-6.

Supplemental Content

Loading ...
Support Center